• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas.

作者信息

Martinsson U, Glimelius B, Hagberg H, Sundström C

机构信息

Department of Oncology, University of Uppsala, Akademiska sjukhuset, Sweden.

出版信息

Eur J Haematol. 1988 Apr;40(4):289-98. doi: 10.1111/j.1600-0609.1988.tb00180.x.

DOI:10.1111/j.1600-0609.1988.tb00180.x
PMID:3366218
Abstract

The prognostic relevance of 4 different serum markers (deoxythymidine kinase = S-TK, lactic dehydrogenase = S-LDH, S-Haptoglobin and S-Orosomucoid) in relation to histopathology according to the Kiel classification, stage and presence or absence of initial symptoms were investigated in 168 consecutive cases of low-grade non-Hodgkin lymphomas (NHL). All serum markers, as well as the other three parameters, gave prognostic information. Univariate analysis yielded a high predictive value (p less than 0.0002) for both S-TK and S-LDH. The best information regarding the probability of survival was, however, obtained from the presence or absence of symptoms from lymphoma manifestations other than those caused by a strictly local tumor mass. Since S-TK and S-LDH correlated well with each other, only the better of them, S-TK, gave information additional to initial symptoms in a multivariate test.

摘要

相似文献

1
Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas.
Eur J Haematol. 1988 Apr;40(4):289-98. doi: 10.1111/j.1600-0609.1988.tb00180.x.
2
Primarily asymptomatic low-grade non-Hodgkin lymphomas: prediction of symptom-free survival and total survival.
Eur J Haematol. 1989 Oct;43(4):332-8. doi: 10.1111/j.1600-0609.1989.tb00308.x.
3
Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis.非霍奇金淋巴瘤Ⅲ期和Ⅳ期的生化标志物与预后:多因素分析
Scand J Haematol. 1984 Jul;33(1):59-67. doi: 10.1111/j.1600-0609.1984.tb02211.x.
4
Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.非霍奇金淋巴瘤患者血清胸苷激酶活性:与其他预后因素的关系。
Klin Wochenschr. 1988 Aug 15;66(16):718-23. doi: 10.1007/BF01726414.
5
Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.非霍奇金淋巴瘤中的血清胸苷激酶,特别关注多发性骨髓瘤。
Anticancer Res. 1997 Jul-Aug;17(4B):3025-9.
6
Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.血清可溶性CD27而非胸苷激酶是惰性非霍奇金淋巴瘤预后的独立预测因素。
Tumour Biol. 2003 Jan-Feb;24(1):53-60. doi: 10.1159/000070661.
7
Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomas.
Eur J Haematol. 1993 May;50(5):258-63. doi: 10.1111/j.1600-0609.1993.tb00159.x.
8
Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.非霍奇金淋巴瘤患者血清中可溶性细胞间黏附分子-1水平升高与肿瘤负荷、疾病活动度及其他预后标志物相关。
Br J Haematol. 1996 Mar;92(3):639-46. doi: 10.1046/j.1365-2141.1996.00377.x.
9
Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.非霍奇金淋巴瘤患者肿瘤细胞及血清中的脱氧胸苷激酶
Br J Cancer. 1995 May;71(5):1099-105. doi: 10.1038/bjc.1995.213.
10
[Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].[恶性非霍奇金淋巴瘤患者组织学分类和分期的预后意义]
Ned Tijdschr Geneeskd. 1993 Apr 17;137(16):815-20.

引用本文的文献

1
Long-term outcome of follicular low-grade lymphoma. A report of 91 patients.
Ann Hematol. 1993 Jun;66(6):303-8. doi: 10.1007/BF01695972.
2
Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.非霍奇金淋巴瘤患者肿瘤细胞及血清中的脱氧胸苷激酶
Br J Cancer. 1995 May;71(5):1099-105. doi: 10.1038/bjc.1995.213.
3
Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.胸苷激酶:一种对非霍奇金淋巴瘤具有预后价值且具有广泛潜在临床应用的肿瘤标志物。
Ann Hematol. 1992 Jul;65(1):1-5. doi: 10.1007/BF01715117.